Global Antibody Market by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, & Antibody-drug Complexes (ADCs)), By End-User (Hospitals, Long-term Care Facilities, & Research Institutes) and by Region – Global Forecast to 2030

MarketResearch.biz announces publication of its most recently generated research report titled, “Global Antibody Market by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, & Antibody-drug Complexes (ADCs)), By End-User (Hospitals, Long-term Care Facilities, & Research Institutes) and by Region – Global Forecast to 2030”, which offers a holistic view of the global antibody market through systematic segmentation that covers every aspect of the target market. The global antibody market is projected to be US$ 155,380 Mn in 2020 to reach US$ 300,777.2 Mn by 2028 at a CAGR of 8.5%.

Request Covid - 19 Impact

Antibodies (also called immunoglobulins) are secreted by B cells to neutralize antigens, such as bacteria and viruses. Generally, all antibodies have the same Y-shaped molecular structure of four polypeptides, with two heavy chains and two light chains. Each Y-terminal is composed of a para-tope (a lock-like structure) specific to a specific epitope (similar to a bond) on the antigen so that these structures can be accurately combined. The ability to bind antigens has led to its widespread use in various life sciences and medicine. According to the way antibodies are produced from lymphocytes, these antibodies are divided into monoclonal and polyclonal. Each of them plays a vital role in the immune system, treatment, and diagnostic tests.

Global Antibody Market Revenue (US$ Mn), 2020–2028

In a favorable economic environment, the antibody market in emerging market countries is expected to maintain growth in the next few years. The demand for these services is expected to remain stable. The strong growth of the pharmaceutical industry, especially in developing economies, is creating many opportunities for this market. Also, increasing research activities in the life sciences industry, coupled with proteomics and genomics research, are expected to drive market growth further.

Increased awareness of recombinant antibodies as potential substitutes may hinder the growth of the target market to a certain extent, and cost of investment associated may hinder the market.

The global antibody market is segmented based on product type, end-user, and region. Based on product type, the market is segmented into monoclonal antibodies, polyclonal antibodies, & antibody-drug complexes (ADC). The monoclonal antibodies segment accounts for the majority share and is expected to witness a significant share in terms of revenue over the forecast period. Based on end-user, the market is segmented into hospitals, long-term care facilities, & research institutes. The hospital segment accounts for significant revenue share, whereas the research institutes segment is projected to register substantial CAGR in the coming years.

Global Antibody Market Attractiveness Analysis by Form, 2014–2030 

By region, the market is segmented into North America, Europe, APAC, South America, and Middle East Africa. Based on region, the North American market is estimated to account for major revenue share and is projected to dominate the global antibody market owing to robust growth in pharmaceuticals and biotechnology industries is a significant factor driving the development of the global antibody market.

Segmentation of the Global Antibody Market:

Segmentation by Product:

• Monoclonal Antibodies
• Polyclonal Antibodies
• Antibody-drug Complexes (ADCs)

Segmentation by End-Use:

• Hospitals
• Long-term Care Facilities
• Research Institutes

Segmentation by Regions:

• North America
• Europe
• APAC
• South America
• MEA